Europe Diabetes Care Devices Market Growth, Size, Trends, Demand, Revenue and Future Outlook
Europe Diabetes Care Devices Market Size- By Monitoring Devices, By Management Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Apr-2024 | Report ID: MEDE2426 | Pages: 1 - 152 | Formats*: |
| Category : Medical Devices | |||
Europe Diabetes Care Devices Market Introduction and Overview
According to SPER Market Research, the Europe Diabetes Care Devices Market is estimated to reach USD XX billion by 2033 with a CAGR of XX%.
The report includes an in-depth analysis of the Europe Diabetes Care Devices Market, including market size and trends, product mix, distribution channels, and supplier analysis. Diabetes care devices are a variety of instruments that help people in efficiently managing their illness. These gadgets are essential for measuring health indicators that are necessary for managing diabetes as well as for monitoring blood glucose levels and giving insulin. With the support of real-time glucose readings and insights into trends and patterns, continuous glucose monitors (CGMs) enable users to make educated decisions regarding their food, level of exercise, and insulin dosage. Insulin pumps provide accurate insulin dosages, simulating the actions of a functional pancreas and providing adaptability in the administration of insulin. Blood glucose meters continue to be essential for routine monitoring because they provide fast and precise results that inform quick decisions.
- Dexcom introduced their real-time CGM system, Dexcom ONE+, in Europe in February 2024. Three distinct body locations can be used to wear the customizable continuous glucose monitoring device Dexcom ONE+.
- June 2022: The Insulin Pen 2.0TM, the newest and most cutting-edge insulin delivery device from Cequr, the pioneer in wearable diabetes technology, was introduced. The pen has an integrated blood glucose meter that allows users to monitor their blood sugar levels throughout the day. It is tiny enough to be worn on the user's body at all times.
Market Opportunities and Challenges
Opportunities: During the projection period, the continuous glucose monitoring segment is anticipated to increase at the fastest rate. In order to utilize a CGM, a tiny sensor and a tiny plastic tube known as a cannula are inserted into the arm or belly, puncturing the upper layer of skin. The sensor can capture glucose readings in interstitial fluid day and night because of an adhesive patch that keeps it in place. In general, the sensors need to be changed every seven to fourteen days. The method transmits real-time measurements wirelessly to a monitor device that displays blood glucose data through a small, reusable transmitter that is linked to the sensor. While some systems display the information via a smartphone app, others have a separate monitor. Expanding knowledge about managing diabetes. Over the course of the forecast period, a number of reasons are anticipated to fuel the expansion of this market, including an expanding pool of patients with diabetes and growing awareness of diabetes treatment and control.
Challenges: Diabetes Care Equipment: Expensive and Difficult to Use Diabetes is a chronic condition that requires regular blood glucose monitoring in order to keep blood sugar levels within normal ranges. The glucose testing apparatus can cause pain and is expensive. Moreover, diabetic care gadgets' outcomes aren't always reliable. Moreover, a few things prevent the market from growing. This includes the uncomfortable insertion of sensors and the challenge of putting several devices on compact frames. Disruptive alarms also lost signal, which led to data gaps, skin discomfort, adhesion problems, and an overwhelming amount of hard-to-understand data produced by diabetes care devices.
Market Competitive Landscape
With few major and generic competitors, the European diabetes care device market is somewhat fragmented. To remain competitive in the market, manufacturers continuously innovated. To achieve market dominance while sticking to organic growth plans, the major players—like Abbott and Medtronic—underwent a number of mergers, acquisitions, and partnerships. The R&D expenditures of major corporations make this clear.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Monitoring Devices, By Management Devices |
| Regions covered | UK, France, Germany, Italy, Spain, Rest of Europe |
| Companies Covered | Abbott Diabetes Care, Agamatrix Inc., Ascensia Diabetes Care, Bionime Corporation, Dexcom Inc., Eli Lilly, Insulet Corporation, Medtronic, LifeScan, Novo Nordisk A/S, Roche Diabetes Care, Rossmax, Sanofi, Others |
COVID-19 Impact on Europe Diabetes Care Devices Market
The COVID-19 epidemic hindered the market expansion for diabetic care devices. Blood glucose levels increased in COVID-19-infected patients. The number of patients increased as a result of elevated blood glucose levels brought on by the stress of infection and the use of steroids for COVID-19 treatment. Market leaders surely benefited from these chances. Due to the increasing incidence of diabetes, numerous players have introduced new cutting-edge diabetes care devices and inked partnerships and agreements related to diabetes care devices. Though this only had a short-term effect on the market for diabetic care devices, lockdowns and travel restrictions caused a disturbance in the supply chain, which in turn led to a shortage of these devices.
Key Target Audience:
- Healthcare providers and professionals specializing in diabetes management
- Medical device manufacturers and suppliers
- Pharmaceutical companies involved in diabetes care
- Healthcare policymakers and regulators
- Investors and financial analysts
- Market research firms and analysts
- Diabetes advocacy groups and patient organizations
- Retailers and distributors of diabetes care products
- Academic and research institutions focusing on diabetes
Our in-depth analysis of the Europe Diabetes Care Devices Market includes the following segments:
| By Monitoring Devices: |
|
| By Management Devices: |
|
| By Region: |
|
Key Topics Covered in the Report:
- Europe Diabetes Care Devices Market Size (FY’2024-FY’2033)
- Overview of Europe Diabetes Care Devices Market
- Segmentation of Europe Diabetes Care Devices Market By Monitoring Devices (Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices)
- Segmentation of Europe Diabetes Care Devices Market By Management Devices (Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors)
- Expansion Analysis of Europe Diabetes Care Devices Market
- Problems and Obstacles in Europe Diabetes Care Devices Market
- Competitive Landscape in the Europe Diabetes Care Devices Market
- Impact of COVID-19 and Demonetization on Europe Diabetes Care Devices Market
- Details on Current Investment in Europe Diabetes Care Devices Market
- Competitive Analysis of Europe Diabetes Care Devices Market
- Prominent Players in the Europe Diabetes Care Devices Market
- SWOT Analysis of Europe Diabetes Care Devices Market
- Europe Diabetes Care Devices Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Europe Diabetes Care Devices Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Diabetes Care Devices Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Diabetes Care Devices Market
7. Europe Diabetes Care Devices Market, By Monitoring Devices (USD Million) 2020-2033
7.1. Europe Diabetes Care Devices Market Size, Share and Forecast, By Monitoring Devices, 2020-20267.2. Europe Diabetes Care Devices Market Size, Share and Forecast, By Monitoring Devices, 2027-20337.3. Self-monitoring Blood Glucose Devices
7.3.1. Glucometer Devices
7.3.2. Blood Glucose Test Strips7.3.3. Lancets7.4. Continuous Glucose Monitoring Devices7.4.1. Sensors7.4.2. Durables
8. Europe Diabetes Care Devices Market, By Management Devices (USD Million) 2020-2033
8.1. Europe Diabetes Care Devices Market Size, Share and Forecast, By Management Devices, 2020-20268.2. Europe Diabetes Care Devices Market Size, Share and Forecast, By Management Devices, 2027-20338.3. Insulin Pump
8.3.1. Insulin Pump Devices8.3.2. Insulin Pump Reservoir8.3.3. Infusion Set
8.4. Insulin Syringes8.5. Cartridges in Reusable Pens8.6. Insulin Disposable Pens8.7. Jet Injectors
9. Europe Diabetes Care Devices Market Forecast, 2020-2033 (USD Million)
9.1. Europe Diabetes Care Devices Market Size and Market Share
10. Europe Diabetes Care Devices Market, By Region, 2020-2033 (USD Million)
10.1. Europe Diabetes Care Devices Market Size and Market Share By Region (2020-2026)10.2. Europe Diabetes Care Devices Market Size and Market Share By Region (2027-2033)10.3. France10.4. Germany10.5. Italy10.6. United Kingdom10.7. Rest of Europe
11. Company Profile
11.1. Abbott Diabetes Care11.1.1. Company details11.1.2. Financial outlook11.1.3. Product summary11.1.4. Recent developments11.2. Agamatrix Inc.11.2.1. Company details11.2.2. Financial outlook11.2.3. Product summary11.2.4. Recent developments11.3. Ascensia Diabetes Care11.3.1. Company details11.3.2. Financial outlook11.3.3. Product summary11.3.4. Recent developments11.4. Bionime Corporation11.4.1. Company details11.4.2. Financial outlook11.4.3. Product summary11.4.4. Recent developments11.5. Dexcom Inc.11.5.1. Company details11.5.2. Financial outlook11.5.3. Product summary11.5.4. Recent developments11.6. Eli Lilly11.6.1. Company details11.6.2. Financial outlook11.6.3. Product summary11.6.4. Recent developments11.7. Insulet Corporation11.7.1. Company details11.7.2. Financial outlook11.7.3. Product summary11.7.4. Recent developments11.8. Medtronic11.8.1. Company details11.8.2. Financial outlook11.8.3. Product summary11.8.4. Recent developments11.9. LifeScan11.9.1. Company details11.9.2. Financial outlook11.9.3. Product summary11.9.4. Recent developments11.10. Novo Nordisk A/S11.10.1. Company details11.10.2. Financial outlook11.10.3. Product summary11.10.4. Recent developments11.11. Roche Diabetes Care11.11.1. Company details11.11.2. Financial outlook11.11.3. Product summary11.11.4. Recent developments11.12. Rossmax11.12.1. Company details11.12.2. Financial outlook11.12.3. Product summary11.12.4. Recent developments11.13. Sanofi11.13.1. Company details11.13.2. Financial outlook11.13.3. Product summary11.13.4. Recent developments11.14. Others
12. List of Abbreviations
13. Reference Links
14. Conclusion
15. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe Diabetes Care Devices Market is projected to reach USD XX billion by 2033, growing at a CAGR of XX % during the forecast period.
Europe Diabetes Care Devices Market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of XX % during the forecast period.
Europe Diabetes Care Devices Market CAGR of XX % during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Diabetes Care Devices Market size is XX billion from 2024 to 2033.
Europe Diabetes Care Devices Market Segment is covered By Monitoring Devices, By Management Devices.
The Europe anticipated to have the highest market share in the Europe Diabetes Care Devices Market .
The key players in the market include Companies Covered Abbott Diabetes Care, Agamatrix Inc., Ascensia Diabetes Care, Bionime Corporation, Dexcom Inc., Eli Lilly, Insulet Corporation, Medtronic, LifeScan, Novo Nordisk A/S, Roche Diabetes Care, Rossmax, Sanofi, Others
Diabetes Care Equipment: Expensive and Difficult to Use Diabetes is a chronic condition that requires regular blood glucose monitoring in order to keep blood sugar levels within normal ranges.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
